The common-and highly illegal–party drug MDMA continues to prove effective in treating post-traumatic stress disorder (PTSD), potentially signaling that the illicit substance could be approved to treat the mental condition down the line. Researchers presented encouraging data from a mid-stage clinical trial of more than 100 PTSD patients during the Psychedelic Science 2017 conference in…

http://fortune.com/2017/05/01/ptsd-fda-mdma-study/

Advertisements